Top Tweets for #exscel
CV outcomes with #exenatide in #T2DM according to ejection fraction: Post-hoc analysis of the Exenatide Study of CV Event Lowering (#EXSCEL) trial
@JavedButler1 @FaiezZANNAD #MiltonPacker
https://t.co/EiTLvfEpF0
@ESC_Journals #EJHF @HanCardiomd @GiuseppeGalati_ @AmrAbdin10

CV outcomes with exenatide in
type 2 diabetes according to EF
#EXSCEL trial evaluating the effects of once-weekly exenatide (EQW) 🆚 placebo on CV outcomes according to baseline LVEF
👥4749 had LVEF available at baseline; 10% LVEF<40%, 90%with LVEF≥40%.
💉Exenatide/sem👇
👉🚫No significant treatment-by-LVEF interactions were observed for MACE, CV💀 or all-cause mortality
👉The risk of 🏥HF was also modified by baseline NYHA class (NYHA class III/IV)
📁 https://t.co/eMMjijEs7k @ESC_Journals

One other issue: In RCTs designed to maintain glycemic equipoise, unbalanced open-label drop-in of SGLT2i & GLP-1RA in PBO may bias towards the null
Drop-in is common & methods available to tease apart its contribution; shown in elegant #EXSCEL analysis:
https://t.co/7MucrbRBNo
I've been thinking about and re-reviewing VERTIS-CV results and am a bit perplexed: it wasn't just one "miss" that was explainable in the context of random chance or empa effect, there were multiple divergent results compared to prior SGLT2i CVOTs (thread)
The #EXSCEL study assessed effects of exenatide on CV outcomes, but aimed for glycemic equipoise. What was impact of open-label drop-in of glucose-lowering meds? Learn more: https://t.co/jDq5QbqcXn #AHAJournals @UniofOxford

Fascinating.
Now 3 GLP-1RA CVOTs to show MACE benefits overall...except in pts w/ established HF. Consistent data from #EXSCEL by @FudimMarat & @robmentz in @CircAHA
Should antihyperglycemic Rx recs be separated for those w/ ASCVD vs. those w/ HF? @JavedButler1 @ShahzebKhanMD
Parsing MACE Results for Semaglutide #T2D (SUSTAIN-6 and PIONEER-6) across varying cardiovascular risk. Reduction of stroke stands out. https://t.co/VZQ8o9WAST

In #EXSCEL, the use of once-weekly exenatide in pts with or without #HF was well tolerated, but the benefits of reduction in all-cause death and first HF hospitalization were attenuated in pts with baseline HF https://t.co/sSGebPbcUz #AHAJournals @FudimMarat @robmentz @DCRINews

(NEJM) Exenatida semanal no es superior a placebo en la prevención de eventos CV en pac con DM2 https://t.co/UnRMCcaIAG ECA #EXSCEL
@dr_kevinlee Injection devices were too scary!
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers



































